البلد: أستراليا
اللغة: الإنجليزية
المصدر: Department of Health (Therapeutic Goods Administration)
Risedronate sodium; Calcium carbonate; Colecalciferol; cholecalciferol
Sanofi-Aventis Australia Pty Ltd
Medicine Registered
Actonel-ec-cmiv2-oct11 1 RISEDRONATE SANOFI ® EC _35MG ONCE-A-WEEK ENTERIC-COATED TABLETS _ _risedronate sodium _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Risedronate Sanofi EC (enteric-coated tablets). It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Risedronate Sanofi EC against the benefits this medicine is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT RISEDRONATE SANOFI EC IS USED FOR Risedronate Sanofi EC is used to treat bone disease and belongs to a group of medicines called bisphosphonates. Risedronate Sanofi EC works directly on your bones to make them stronger and therefore less likely to break or fracture. Risedronate Sanofi EC is used to treat: osteoporosis (brittle or fragile bones that may fracture easily) osteoporosis caused by taking steroids _UNDERSTANDING BONE _ Bone is a living tissue consisting of calcium and other minerals. Throughout life, old bone is constantly broken down and replaced with new bone. After the age of 35, bone loss may occur faster than your body can replace it. If you lose too much bone then they become weaker and are more likely to break. _OSTEOPOROSIS _ Osteoporosis (brittle bone disease) is a disease that causes bones to become weaker. Weak bones break (fracture) easily. Many patients with osteoporosis have no symptoms and may not even know that they have osteoporosis. However osteoporosis makes you more likely to break bones when you have a fall or bump. The اقرأ الوثيقة كاملة
_Risedronate Sanofi ec-23feb11 _ _ _ _Page 1 _ PRODUCT INFORMATION RISEDRONATE SANOFI EC, RISEDRONATE SANOFI EC COMBI & RISEDRONATE SANOFI EC COMBI D NAME OF THE MEDICINE NON-PROPRIETARY NAME Risedronate Each Risedronate Sanofi EC enteric-coated tablet contains the equivalent of 35 mg of anhydrous risedronate sodium in the form of the hemi-pentahydrate with small amounts of monohydrate. The empirical formula for risedronate sodium is C 7 H 10 NO 7 P 2 Na. The chemical name of risedronate sodium is [1-hydroxy-2-(3- pyridinyl)ethylidene]bis(phosphonic acid) monosodium salt. Calcium Carbonate Tablet Risedronate Sanofi EC Combi also contains 1250 mg calcium carbonate tablets. Each calcium tablet contains 1250 mg calcium carbonate, which is equivalent to 500 mg elemental calcium. Calcium Carbonate/Cholecalciferol Sachet Risedronate Sanofi EC Combi D also contains calcium carbonate/cholecalciferol sachets. Each sachet contains 2500 mg calcium carbonate and 22 g (880 IU) cholecalciferol, which is equivalent to 1000 mg elemental calcium and 22 g (880 IU) vitamin D3. The terms cholecalciferol and vitamin D3 are equivalent. The chemical name of cholecalciferol is (5Z,7E)-9,10-secocholesta- 5,7,10(19)-trien-3β-ol. Molecular formula: C 27 H 44 O. CHEMICAL STRUCTURE The chemical structure of risedronate sodium is the following: Molecular Weight Anhydrous: 305.10 Hemi-pentahydrate: 350.13 The CAS registry number is 115436-72-1 The chemical structure of cholecalciferol: Molecular Weight: 384.6 The CAS registry number is 67-97-0 _Risedronate Sanofi ec-23feb11 _ _ _ _Page 2 _ DESCRIPTION Risedronate sodium is a fine, white to off-white, odourless, crystalline powder. It is soluble in water and in aqueous solutions and essentially insoluble in common organic solvents. Calcium carbonate is a white powder, practically ins اقرأ الوثيقة كاملة